h1

h2

h3

h4

h5
h6
%0 Journal Article
%A Barratt, Jonathan
%A Lafayette, Richard
%A Kristensen, Jens
%A Stone, Andrew
%A Cattran, Daniel
%A Flöge, Jürgen
%A Tesar, Vladimir
%A Trimarchi, Hernán
%A Zhang, Hong
%A Eren, Necmi
%A Paliege, Alexander
%A Rovin, Brad H.
%T Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
%J Kidney international
%V 103
%N 2
%@ 2157-1724
%C New York, NY
%I Elsevier
%M RWTH-CONV-250008
%P 391-402
%D 2022
%Z Available online 19 October 2022
%F PUB:(DE-HGF)16
%9 Journal Article
%U <Go to ISI:>//WOS:000922298000001
%$ pmid:36270561
%R 10.1016/j.kint.2022.09.017
%U https://publications.rwth-aachen.de/record/862041